Histology-tailored multidisciplinary management of primary retroperitoneal sarcomas.

Chemotherapy Diagnosis Liposarcoma Radiotherapy Retroperitoneal sarcoma Retroperitoneal tumour Solitary fibrous Tumor Surgery leiomyosarcoma

Journal

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
ISSN: 1532-2157
Titre abrégé: Eur J Surg Oncol
Pays: England
ID NLM: 8504356

Informations de publication

Date de publication:
06 2023
Historique:
received: 03 02 2022
revised: 02 05 2022
accepted: 11 05 2022
medline: 29 5 2023
pubmed: 23 5 2022
entrez: 22 5 2022
Statut: ppublish

Résumé

Until recently, the recommendation for primary retroperitoneal sarcomas (RPS) was to perform a complete en-bloc gross excision, (neo) adjuvant treatments being options which were not validated by randomized studies, with a large discrepancy of use between centers. The heterogeneity of RPS, with their different biological behaviour, renders a homogenous therapeutic and surgical approach probably inappropriate. Recent studies, both surgical and dedicated to adjuvant treatments, allow refining these recommendations. This review summarizes recent advances and directions.

Identifiants

pubmed: 35599138
pii: S0748-7983(22)00435-8
doi: 10.1016/j.ejso.2022.05.010
pii:
doi:

Types de publication

Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1061-1067

Informations de copyright

Copyright © 2022 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors have no potential conflicts of interest to disclose.

Auteurs

S Bonvalot (S)

Department of Surgical Oncology, Institut Curie, Paris University, Paris, France. Electronic address: Sylvie.bonvalot@curie.fr.

C Roland (C)

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

C Raut (C)

Division of Surgical Oncology, Department of Surgery, Brigham and Women's Hospital, Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

C Le Péchoux (C)

Department of Radiation Oncology, Gustave Roussy, Villejuif, France.

D Tzanis (D)

Department of Surgical Oncology, Institut Curie, Paris University, Paris, France.

A M Frezza (AM)

Department of Cancer Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

A Gronchi (A)

Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH